Perrigo (NYSE:PRGO) Releases FY 2026 Earnings Guidance

Key Points

• Perrigo updated FY2026 guidance to EPS of 2.250–2.550 (consensus 2.11) and revenue of $4.0B–$4.2B (consensus $4.1B).
• The company announced a quarterly dividend of $0.29 (annualized $1.16), implying a 10.0% yield; the ex-dividend date is May 29 and the payout is scheduled for June 16.
• Analysts hold a consensus "Hold" rating with a $19.33 price target; shares trade around $11.60 (market cap $1.6B) and Perrigo recently reported an EPS beat ($0.43 vs. $0.31) but missed revenue ($841.8M vs. $1.04B) and showed a negative net margin of 33.51%.

Perrigo (NYSE:PRGO - Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.250-2.550 for the period, compared to the consensus estimate of 2.110. The company issued revenue guidance of $4.0 billion-$4.2 billion, compared to the consensus revenue estimate of $4.1 billion.

Wall Street Analyst Weigh In

A number of brokerages recently commented on PRGO. Jefferies Financial Group reaffirmed a "hold" rating on shares of Perrigo in a research note on Thursday, February 26th. Zacks Research raised Perrigo from a "strong sell" rating to a "hold" rating in a research report on Monday, April 27th. Weiss Ratings lowered Perrigo from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, April 29th. Canaccord Genuity Group lowered their price objective on Perrigo from $20.00 to $17.00 and set a "buy" rating for the company in a research report on Friday, February 27th. Finally, Argus raised Perrigo to a "hold" rating in a research report on Wednesday, January 14th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $19.33.

Perrigo Price Performance

Shares of NYSE:PRGO opened at $11.60 on Wednesday. Perrigo has a 1-year low of $9.23 and a 1-year high of $28.43. The company has a debt-to-equity ratio of 1.23, a current ratio of 2.76 and a quick ratio of 1.63. The business has a fifty day moving average price of $11.10 and a 200-day moving average price of $13.72. The company has a market capitalization of $1.60 billion, a PE ratio of -1.13, a PEG ratio of 1.34 and a beta of 0.52.

Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.31 by $0.12. Perrigo had a positive return on equity of 9.41% and a negative net margin of 33.51%.The company had revenue of $841.80 million during the quarter, compared to the consensus estimate of $1.04 billion. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities analysts expect that Perrigo will post 2.12 EPS for the current fiscal year.

Perrigo Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Friday, May 29th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 10.0%. The ex-dividend date is Friday, May 29th. Perrigo's dividend payout ratio (DPR) is presently -11.28%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of PRGO. Fuller & Thaler Asset Management Inc. boosted its position in Perrigo by 291.9% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company's stock worth $108,921,000 after purchasing an additional 5,828,076 shares during the last quarter. Invesco Ltd. lifted its position in shares of Perrigo by 134.2% during the 4th quarter. Invesco Ltd. now owns 4,542,415 shares of the company's stock valued at $63,230,000 after buying an additional 2,602,724 shares in the last quarter. ION Fund Management Ltd purchased a new position in shares of Perrigo during the 4th quarter valued at about $24,499,000. Ion Asset Management Ltd. lifted its position in shares of Perrigo by 34.7% during the 2nd quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company's stock valued at $102,007,000 after buying an additional 983,727 shares in the last quarter. Finally, Bridgeway Capital Management LLC purchased a new position in shares of Perrigo during the 4th quarter valued at about $9,165,000. 95.91% of the stock is owned by hedge funds and other institutional investors.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo's focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo's operations span research and development, manufacturing, quality assurance and global distribution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.